A. Impens

发表

Randomized Placebo-Controlled Crossover Trial of Tadalafil in Raynaud's Phenomenon Secondary to Systemic Sclerosis

V. Hsu, E. Schiopu, A. Impens, 2010 .

Concise report Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis

R. Hays, M. Mayes, D. Furst, 2011 .

Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis.

R. Hays, M. Mayes, D. Furst, 2011, Rheumatology.

Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis

G. Haines, A. Koch, J. Seibold, 2011, Arthritis Research & Therapy.

Vasodilatory Therapeutics in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Cohort

B. Segal, J. Gordon, M. Murtaugh, 2012 .

The 6-minute walk test in scleroderma--how measuring everything measures nothing.

J. Seibold, S. Wangkaew, A. Impens, 2008, Rheumatology.

PDE-5 Inhibitors in Scleroderma Raynaud Phenomenon and Digital Ulcers: Current Status of Clinical Trials

K. Phillips, E. Schiopu, A. Impens, 2011, International journal of rheumatology.

Digital Ischemia in Scleroderma Spectrum of Diseases

K. Phillips, E. Schiopu, A. Impens, 2010, International journal of rheumatology.

Randomized Placebo-Controlled Crossover Trial of Tadalafil in Raynaud’s Phenomenon Secondary to Systemic Sclerosis

J. Seibold, V. Hsu, K. Phillips, 2009, The Journal of Rheumatology.

The Journal of Rheumatology Phenomenon Secondary to Systemic Sclerosis Randomized Placebo-Controlled Crossover Trial of Tadalafil in Raynaud's

V. Hsu, K. Phillips, E. Schiopu, 2009 .

Missing expectations: Windlass tourniquet use without formal training yields poor results

F. Bokhari, F. Bajani, L. Tatebe, 2019, The journal of trauma and acute care surgery.

Screening psychiatric emergency department patients with major mental illnesses for at-risk drinking.

F. Blow, K. Barry, D. Welsh, 2006, Psychiatric services.

New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN).

R. Steele, M. Suarez‐Almazor, B. Thombs, 2012, Clinical and experimental rheumatology.

Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.

R. Hays, M. Mayes, D. Furst, 2009, Arthritis and rheumatism.

Why do they care? Narratives of physician volunteers on motivations for participation in short‐term medical missions abroad

W. Groot, M. Pavlova, A. Impens, 2018, The International journal of health planning and management.

A systematic review of social, economic and diplomatic aspects of short-term medical missions

W. Groot, M. Pavlova, A. Impens, 2015, BMC Health Services Research.

Exploring Sources of Emotional Distress among People Living with Scleroderma: A Focus Group Study

B. Thombs, M. Hudson, M. Carrier, 2016, PloS one.

The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context

R. Steele, M. Suarez‐Almazor, B. Levis, 2013, BMJ Open.

Title The Scleroderma Patient-centered Intervention Network ( SPIN ) Cohort : Protocol for a cohort multiple randomised controlled trial ( cmRCT ) design to support trials of psychosocial and rehabilitation interventions in a rare disease context Permalink

R. Steele, M. Suarez‐Almazor, B. Levis, 2013 .

Minimally Important Differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument

R. Hays, M. Mayes, D. Furst, 2011, The Journal of Rheumatology.

Economic assessment of US physician participation in short-term medical missions

W. Groot, M. Pavlova, A. Impens, 2016, Globalization and Health.

Discordance between Patient and Physician Assessments of Disease Severity in Systemic Sclerosis

R. Steele, B. Thombs, M. Hudson, 2010, The Journal of Rheumatology.

Vascular Alterations and Sexual Function in Systemic Sclerosis

J. Seibold, A. Impens, 2010, International journal of rheumatology.

Sexual activity and functioning in female scleroderma patients.

J. Seibold, R. Rosen, J. Cole, 2009, Clinical and experimental rheumatology.

The Windlass Tourniquet: Is It Taking the Wind Out of the "Stop the Bleed" Sails?

F. Bajani, V. P. Karalius, L. Tatebe, 2021, The Journal of surgical research.

Does Osteopathic Manipulative Treatment Make a Neuropsychological Difference in Adults With Pain? A Rationale for a New Approach

A. Koronkiewicz, Kurt P. Heinking, Mireille N. Rizkalla, 2018, The Journal of the American Osteopathic Association.

Randomized placebo-controlled crossover trial of tadalafil in Raynaud's phenomenon secondary to systemic sclerosis.

J. Seibold, V. Hsu, K. Phillips, 2009, The Journal of rheumatology.

Demographic profile of physician participants in short-term medical missions

W. Groot, M. Pavlova, A. Impens, 2016, BMC Health Services Research.

The Physicians’ Giving Back Survey: Keeping up with American generosity

W. Groot, M. Pavlova, A. Impens, 2015 .

Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis

B. Kahaleh, K. Phillips, B. Rabquer, 2011, Arthritis Research & Therapy.

Minimally Important Differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument

R. Hays, M. Mayes, D. Furst, 2011, Journal of Rheumatology.

The 6-minute walk test in scleroderma--how measuring everything measures nothing.

S. Wangkaew, A. Impens, James R. Seibold, 2008, Rheumatology.